Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Hepatology. 2018 Dec 27;69(1):420–430. doi: 10.1002/hep.30150

Table 1.

Selected studies that identify DR in human patients

Disease Cells detected Markers used
Primary biliary cholangitis Cholangiocytes/HPCs CK19, EpCAM, OV6 (34)
Primary sclerosing cholangitis Cholangiocytes/HPCs CK19, EpCAM, OV6 (34)
Biliary atresia Cholangiocytes CK7 (35)
Alcoholic hepatitis Cholangiocytes/HPCs CK7, EpCAM (36)
Alcoholic hepatitis Cholangiocytes CK7, CK19 (37)
Non-alcoholic steatohepatitis Cholangiocytes CK7 (2)
Hepatitis B virus-positive liver cirrhosis Cholangiocytes CK19 (38)
Hepatitis C virus-positive liver cirrhosis Cholangiocytes CK19 (38)
Hepatitis C virus recurrence Cholangiocytes CK7 (39)
Hepatitis C virus recurrence Cholangiocytes CK7 (40)
Hepatitis B virus-related hepatocellular carcinoma Cholangiocytes CK19 (41)
hepatocellular carcinoma after hepatectomy Cholangiocytes CK7 (42)
hepatocellular carcinoma Cholangiocytes CK7 (43)